SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-285782
Filing Date
2018-09-27
Accepted
2018-09-27 17:03:58
Documents
1
Period of Report
2018-09-26
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d631444d8k.htm 8-K 14437
  Complete submission text file 0001193125-18-285782.txt   15709
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35405 | Film No.: 181091653
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences